These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 7563004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
    Gené A, González-Cuevas A, Juncosa T, Luaces C, Latorre C.
    Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
    [Abstract] [Full Text] [Related]

  • 23. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H, Kobayashi T, Okitsu N, Aoki A, Toriya M, Nakada Y, Sagai H, Iyobe S, Inoue M.
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z, Rosenberg S, Soffer Y, Dan M.
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-inflammatory activity of macrolide antibiotics.
    Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombolà L, Carnuccio R, Iuvone T, D'Acquisto F, Di Rosa M.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):156-63. PubMed ID: 10604943
    [Abstract] [Full Text] [Related]

  • 30. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV, Brasili S, Saiz M, Carranza C, Vidal P, Calderón J, Lopardo HA.
    Medicina (B Aires); 2000 Jan; 60(4):487-90. PubMed ID: 11188957
    [Abstract] [Full Text] [Related]

  • 31. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
    Katosova LK, Lazareva AV, Khokhlova TA, Ponomarenko OA, Alyabieva NM.
    Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
    [Abstract] [Full Text] [Related]

  • 32. In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Banche G, Roana J, Allizond V, Andreotti S, Malabaila A, Li Vigni N, Mandras N, Scalas D, Tullio V, Carlone NA, Savoia D, Gaido E, Barbui A, Cuffini AM.
    Lett Appl Microbiol; 2008 Oct; 47(4):309-14. PubMed ID: 19241525
    [Abstract] [Full Text] [Related]

  • 33. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V, Zavadilová J, Fabiánová K, Urbášková P.
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [Abstract] [Full Text] [Related]

  • 35. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [Abstract] [Full Text] [Related]

  • 36. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
    Girard AE, Cimochowski CR, Faiella JA.
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():29-37. PubMed ID: 8396094
    [Abstract] [Full Text] [Related]

  • 37. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.
    Clin Infect Dis; 2005 Sep 01; 41(5):599-608. PubMed ID: 16080080
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
    Guggenbichler JP, Georgopoulos A, Scharrer P, Kobilansky C, Mühlbacher J, Georgopoulos M, Dierich MP.
    Infection; 1993 Sep 01; 21(4):259-61. PubMed ID: 8225634
    [Abstract] [Full Text] [Related]

  • 39. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S, Noviello S, Ianniello F.
    J Chemother; 2000 Dec 01; 12(6):475-81. PubMed ID: 11154028
    [Abstract] [Full Text] [Related]

  • 40. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P, Doit C, Deforche D, Brahimi N, Francois M, Van den Abbeele T, Bingen E.
    Pathol Biol (Paris); 2004 Oct 01; 52(8):489-92. PubMed ID: 15465270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.